Posted by Michael Wonder on 02 Sep 2021
Pfizer’s acromegaly treatment receives reimbursement
2 September 2021 - Pfizer Korea said Thursday that the Ministry of Health and Welfare would begin to reimburse Somavert, its acromegaly treatment, from this month.
With the reimbursement, patients will have to pay 64,166 won ($55.36) for 10mg vial, 93,041 won for 15 mg vial, 121,915 won for 20 mg vial, 150,790 won for 25 mg vial and 179,665 won for 30 mg vial.
